Quiz Summary
0 of 10 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 10 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 10
1. Question
1.) The primary goal of adjusting antibiotic dosing regimens in patients undergoing hemodialysis is:
-
Question 2 of 10
2. Question
2.) Which of the following does not require dose adjustment in patients undergoing hemodialysis?
-
Question 3 of 10
3. Question
3.) _______ is the PK/PD index which best correlates with tobramycin efficacy.
-
Question 4 of 10
4. Question
4.) Drug related factors most influencing dialysis clearance include:
-
Question 5 of 10
5. Question
5.) Close therapeutic drug monitoring is advisable for which of the following:
-
Question 6 of 10
6. Question
6.) In patients undergoing hemodialysis vancomycin plasma level is influenced by the following:
-
Question 7 of 10
7. Question
7.) Ciprofloxacin is a fluoroquinolone antibiotic with concentration-dependent bactericidal activity. It is commonly used in the treatment of urinary tract infections (UTI), and primarily eliminated by the kidneys. The standard oral dosing regimen to treat complicated UTI in adults is 500 mg given every 12 hours for 5-7 days. Based on this information, which of the following dosing regimens is most appropriate in a patient undergoing hemodialysis?
-
Question 8 of 10
8. Question
8.) Although vancomycin is significantly removed by dialysis, it is typically infused over the last hour of dialysis
-
Question 9 of 10
9. Question
9.) Targeting a high Cmax:MIC ratio for tobramycin dosing by administering conventional doses at extended intervals
-
Question 10 of 10
10. Question
10.) _______ is the target predialysis vancomycin serum trough concentration for treating MRSA infections in patients undergoing hemodialysis